Skip to main content
ArticleOPEN ACCESS

Correction: MPT0B169, a new antitubulin agent, inhibits Bcr-Abl expression and induces mitochondrion-mediated apoptosis in nonresistant and imatinib-resistant chronic myeloid leukemia cells (PLoS ONE (2016) 11:1 (e0148093) DOI: 10.1371/journal.pone.0148093)

PLoS ONE
DOI: 10.1371/journal.pone.0186531
1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

The affiliation for the third author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Cite

CITATION STYLE

APA

Wong, S. M., Liu, F. H., Lee, Y. L., & Huang, H. M. (2017, October 1). Correction: MPT0B169, a new antitubulin agent, inhibits Bcr-Abl expression and induces mitochondrion-mediated apoptosis in nonresistant and imatinib-resistant chronic myeloid leukemia cells (PLoS ONE (2016) 11:1 (e0148093) DOI: 10.1371/journal.pone.0148093). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0186531

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free